share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-10% Owner Merck & Co., Inc.

SEC announcement ·  Mar 11 15:32
Summary by Moomoo AI
Merck & Co., Inc. has engaged in a significant transaction involving the purchase of Harpoon Therapeutics, Inc. (HARP) common stock. On March 11, 2024, Merck & Co. acquired 21,397,205 shares of Harpoon Therapeutics at a price of $23.00 per share. Following this transaction, Merck & Co. holds a total of 1,000 shares in Harpoon Therapeutics. The transaction is currently in progress and reflects a direct ownership type, as indicated in the acquisition log.
Merck & Co., Inc. has engaged in a significant transaction involving the purchase of Harpoon Therapeutics, Inc. (HARP) common stock. On March 11, 2024, Merck & Co. acquired 21,397,205 shares of Harpoon Therapeutics at a price of $23.00 per share. Following this transaction, Merck & Co. holds a total of 1,000 shares in Harpoon Therapeutics. The transaction is currently in progress and reflects a direct ownership type, as indicated in the acquisition log.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more